Standard

Лекарственные препараты передовой терапии: перспективы внедрения в клиническую практику в педиатрии. / Гомон, Ю. М.; Колбин, Алексей Сергеевич.

In: ВОПРОСЫ СОВРЕМЕННОЙ ПЕДИАТРИИ, Vol. 23, No. 1, 25.02.2024, p. 34-47.

Research output: Contribution to journal › Article › peer-review

Harvard

Гомон, ЮМ & Колбин, АС 2024, 'Лекарственные препараты передовой терапии: перспективы внедрения в клиническую практику в педиатрии', ВОПРОСЫ СОВРЕМЕННОЙ ПЕДИАТРИИ, vol. 23, no. 1, pp. 34-47. https://doi.org/10.15690/vsp.v23i1.2654

APA

Гомон, Ю. М., & Колбин, А. С. (2024). Лекарственные препараты передовой терапии: перспективы внедрения в клиническую практику в педиатрии. ВОПРОСЫ СОВРЕМЕННОЙ ПЕДИАТРИИ, 23(1), 34-47. https://doi.org/10.15690/vsp.v23i1.2654

Vancouver

Гомон ЮМ, Колбин АС. Лекарственные препараты передовой терапии: перспективы внедрения в клиническую практику в педиатрии. ВОПРОСЫ СОВРЕМЕННОЙ ПЕДИАТРИИ. 2024 Feb 25;23(1):34-47. https://doi.org/10.15690/vsp.v23i1.2654

Author

Гомон, Ю. М. ; Колбин, Алексей Сергеевич. / Лекарственные препараты передовой терапии: перспективы внедрения в клиническую практику в педиатрии. In: ВОПРОСЫ СОВРЕМЕННОЙ ПЕДИАТРИИ. 2024 ; Vol. 23, No. 1. pp. 34-47.

BibTeX

@article{bb4310eb281e424f9392af8d6409bdae,
title = "Лекарственные препараты передовой терапии: перспективы внедрения в клиническую практику в педиатрии",
abstract = "The article discusses classifications of medicines for gene and cell therapy. Data on medicinal products registered in Russia, as well as in the European Union countries, Great Britain, USA, and Japan is presented. The limitations on using such medicinal products were considered, including their high utilitarian cost and high risk of adverse events. The potential for increasing clinical efficacy and economic feasibility of advanced therapies (pediatrics included) has been analyzed.",
keywords = "advanced medical technologies, cell therapy, gene therapy, registration",
author = "Гомон, {Ю. М.} and Колбин, {Алексей Сергеевич}",
year = "2024",
month = feb,
day = "25",
doi = "10.15690/vsp.v23i1.2654",
language = "русский",
volume = "23",
pages = "34--47",
journal = "ВОПРОСЫ СОВРЕМЕННОЙ ПЕДИАТРИИ",
issn = "1682-5527",
publisher = "Publishing House of the Union of Pediatricians",
number = "1",

}

RIS

TY - JOUR

T1 - Лекарственные препараты передовой терапии: перспективы внедрения в клиническую практику в педиатрии

AU - Гомон, Ю. М.

AU - Колбин, Алексей Сергеевич

PY - 2024/2/25

Y1 - 2024/2/25

N2 - The article discusses classifications of medicines for gene and cell therapy. Data on medicinal products registered in Russia, as well as in the European Union countries, Great Britain, USA, and Japan is presented. The limitations on using such medicinal products were considered, including their high utilitarian cost and high risk of adverse events. The potential for increasing clinical efficacy and economic feasibility of advanced therapies (pediatrics included) has been analyzed.

AB - The article discusses classifications of medicines for gene and cell therapy. Data on medicinal products registered in Russia, as well as in the European Union countries, Great Britain, USA, and Japan is presented. The limitations on using such medicinal products were considered, including their high utilitarian cost and high risk of adverse events. The potential for increasing clinical efficacy and economic feasibility of advanced therapies (pediatrics included) has been analyzed.

KW - advanced medical technologies

KW - cell therapy

KW - gene therapy

KW - registration

UR - https://www.mendeley.com/catalogue/13ba80e3-b13f-32f7-9d2b-607794f39e67/

U2 - 10.15690/vsp.v23i1.2654

DO - 10.15690/vsp.v23i1.2654

M3 - статья

VL - 23

SP - 34

EP - 47

JO - ВОПРОСЫ СОВРЕМЕННОЙ ПЕДИАТРИИ

JF - ВОПРОСЫ СОВРЕМЕННОЙ ПЕДИАТРИИ

SN - 1682-5527

IS - 1

ER -

ID: 128150926